German doctors report that teclistamab, a drug initially developed for multiple myeloma, significantly improved symptoms in two women suffering from severe autoimmune neuropathy that had resisted all standard treatments. Following just four injections, both patients showed disappearance of harmful antibodies, reduced nerve damage, and notable gains in walking ability, sensation, and daily functioning. The findings […]
